Value Investing Lab @lab_value1733

$DLO Q2 Earnings: - Revenue of $256.5M vs. $229.7M est. 🟢 - Adj. EBITDA of $70.1M vs. $55.8M est. 🟢 GAAP EPS of $0.14 vs. $0.12 est. 🟢 FY2025 Guidance: - Revenue of ~$1.01B vs. $958.2M est. 🟢 - Adj. EBITDA of ~$274M vs. $240.9M est. 🟢

Novo Nordisk $NVO - A Cash Machine in Diabetes & Obesity Care 🔥85% Gross Margins 📈20% EPS Growth (2Yr) ✅Dominates GLP-1 drugs ✅ROIC: 35% ✅Undervalued? Fwd PE: 12x (vs 30x 5yr avg) ⚠️Risks: Pricing pressure, biosimilars Combo of growth, profitability & cash flow. Thoughts?

Microsoft $MSFT– Cloud & AI Titan 🔥 44.9% Margin 💰 $94.3B Net Cash 📈 23% EPS Growth ✅ Azure: $75B Revenue (+34%) ✅ ROIC: 27.5% ✅ 100M+ Copilot Users | 500T+ AI Tokens ⚠️ Risks: AWS competition, regulation, $64.6B FY25 capex 32x forward P/E, fair price for this growth beast?

$META - The AI & Ad Powerhouse 🔥 43% Operating Margin 💰 $47.1B Net Cash 📈 22% EPS Growth (YoY) ✅ Dominates digital ads (3.48B daily users) ✅ ROIC: 27.5% ✅ AI Leader ⚠️ Risks: Regulatory scrutiny Cash-generating titan trading at 30x fwd PE. Fair for this growth? Thoughts?

Alphabet $GOOG – Digital Ad & AI Juggernaut 🔥55% Gross Margins 📈23% EPS Growth (2-Yr) ✅Dominates Search, YouTube & Cloud AI ✅ROIC: 28% ✅Fwd PE ~20x (vs 25x 5-yr avg) ⚠️Risks: Antitrust headwinds, AI competition A tech titan printing cash while scaling the future. Thoughts?

Microsoft continues to lead global tech with strong growth: Cloud now 43% of revenue, 22% 10yr CAGR and 70%+ gross margin. Heavy AI investment, robust capital returns, and Nadella’s steady leadership keep $MSFT well-positioned despite regulatory and competitive risks.

Shopify $SHOP Q2 2025: Revenue up 31% to $2.68B, GMV surged to $87.8B with strong Europe growth (+42%), operating income $291M beats estimates, free cash flow margin steady at 16%. Q3 outlook: revenue growth mid-to-high 20%s YoY, gross profit up low 20%s. #SHOP #Earnings

Uber $UBER Q2 2025: Revenue +18% YoY to $12.7B, net income $1.36B, 3.3B trips (+18%), adjusted EBITDA +35% to $2.1B. Announces $20B buyback. Strong growth across platform, 180M active users. Confident outlook for Q3.

Disney $DIS Q2 2025: Revenue up 7% to $23.6B, adjusted EPS up 20% to $1.45 (beat forecasts); Disney+ adds 1.4M subs, boosts full-year EPS guidance, stock jumps ~10%. Parks & streaming drive growth; new Abu Dhabi park announced.

McDonald’s $MCD Q2 2025 Earnings: - Revenue $6.84B (+5%), adj. EPS $3.19 (+7%). Global same-store sales up 3.8%, led by international growth. - Beat estimates on profit and sales, driven by menu innovation and loyalty programs. $MCD #Earnings.

Novo Nordisk $NVO Q2 2025: Revenue up 18% YoY to DKK 154.9B; Wegovy sales surged 67%. EPS of $12.49 crushed estimates. New CEO at helm as company maintains robust growth in obesity/diabetes drug sales, slightly missing some analyst targets but beating others. #earnings #NVO

$TOST TOAST Q2 2025: Record 8,500+ new locations, ARR up 31% to $1.9B, recurring gross profit +35% YoY. Net income $80M, adj. EBITDA $161M. Launched Toast Go® 3 & announced Amex partnership. Expanding in US & globally. #RestaurantTech #Earnings

Supermicro $SMCI Q3 2025: Revenue $4.6B (missed estimates), EPS $0.31 (beat by $0.01). Margin pressures persisted at 9.7%, but AI & GPU platforms drove >70% of sales. CEO stays bullish on long-term AI growth despite near-term delays. #earnings #AI #SMCI

Coupang $CPNG Q2 2025: Net revenue $8.5B (+16% YoY, +19% FX-neutral); Gross profit $2.6B (+20% YoY); Operating income $149M, up $174M YoY; Net income $32M, EPS $0.02; Adjusted EBITDA $428M with 5% margin. Product Commerce active customers grew 10% to 23.9M. #CPNG

Zoetis $ZTS Q2 2025 earnings beat expectations with revenue of $2.46B (+4.2% YoY) and net income of $718M (+15.1%). EPS rose to $1.61 from $1.37. Strong growth in companion animal segment (+8.4%), raised FY 2025 outlook, driven by margin expansion and product strength.

Suncor Energy $SU Q2 2025 earnings showed an expected EPS around $0.50 to $0.58, marking a 46%+ YoY decline, with revenues dropping nearly 20% to about $7.6-$8 billion. Higher oil sands output helped offset some impact, but refining margins and trade risks pressured results.

Marriott $MAR Q2 2025 earnings beat expectations with revenue up 4.7% YoY to $6.74B and adjusted EPS of $2.65, slightly above estimates. RevPAR rose 5.4% YoY. Operating margin steady at 18.3%. Full-year EPS guidance reaffirmed near $9.85-$10.08

$BP Q2 2025 earnings: underlying net income $2.4B, operating cash flow $6.3B, upstream production +3%, dividend up 4%, and $750M share buyback announced. Strong operational performance with 5 major project start-ups and improved refining margins. Stock rose 2.3%

Duke Energy $DUK Q2 2025 highlights: Revenue up 4.7% to $7.51B, net income $984M, EPS $1.25 beats estimates, driven by new rates and strategic moves; reaffirming 2025 EPS guidance $6.17-$6.42. Strategic transactions support $87B capital plan for energy transition.

Pfizer $PFE reported strong Q2 2025 results with $14.7B revenue (+10% YoY) and adjusted EPS of $0.78, beating estimates. They raised 2025 EPS guidance to $2.90-$3.10 and maintained revenue guidance of $61B-$64B, driven by growth in Vyndaqel, Eliquis, and COVID-19 products.